$391 Million is the total value of SECTOR GAMMA AS's 28 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 18.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Sell | MEDTRONIC PLC | $25,694,479 | -15.8% | 327,903 | -5.4% | 6.57% | -3.9% |
| CAH | Sell | CARDINAL HEALTH INC | $22,932,288 | -37.0% | 264,136 | -31.3% | 5.86% | -28.0% |
| BDX | Sell | BECTON DICKINSON & CO | $18,584,171 | -24.2% | 71,884 | -22.6% | 4.75% | -13.5% |
| CNC | Sell | CENTENE CORP DEL | $15,370,434 | -7.0% | 223,148 | -8.9% | 3.93% | +6.2% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $13,039,500 | -26.1% | 64,857 | -11.3% | 3.33% | -15.6% |
| THC | Sell | TENET HEALTHCARE CORP | $10,408,973 | -20.8% | 157,975 | -2.2% | 2.66% | -9.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,498,327 | -39.7% | 96,048 | -41.0% | 2.17% | -31.2% |
| BAX | Sell | BAXTER INTL INC | $7,292,991 | -66.2% | 193,243 | -59.2% | 1.86% | -61.4% |
| BRKR | Sell | BRUKER CORP | $6,439,017 | -22.4% | 103,355 | -7.9% | 1.65% | -11.3% |
| QGEN | Sell | QIAGEN NV | $4,078,877 | -29.0% | 100,713 | -21.0% | 1.04% | -18.9% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $3,746,719 | -22.1% | 179,785 | -10.4% | 0.96% | -10.9% |
| AMED | Sell | AMEDISYS INC | $2,296,239 | -64.6% | 24,585 | -65.4% | 0.59% | -59.6% |
| VIR | Sell | VIR BIOTECHNOLOGY INC | $1,391,801 | -62.3% | 148,538 | -1.2% | 0.36% | -56.9% |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -56,577 | -100.0% | -0.52% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -26,471 | -100.0% | -0.98% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -266,370 | -100.0% | -2.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.